Drive Therapeutics

Chapel Hill, United States

Drive Therapeutics is a new biotechnology company that strives to improve treatment for retinal diseases.

Sep 2022

Grant

Biotechnology Health Care Therapeutics

Top Investors

National Science FoundationNorth Carolina Biotechnology CenterOne North Carolina Small Business Program

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Drive Therapeutics

Who are Drive Therapeutics's investors?

Drive Therapeutics's investors include National Science Foundation, North Carolina Biotechnology Center, One North Carolina Small Business Program.

Where is Drive Therapeutics headquartered?

Drive Therapeutics is headquartered in Chapel Hill, United States.

What does Drive Therapeutics do?

Drive Therapeutics is a new biotechnology company that strives to improve treatment for retinal diseases.

What stage is Drive Therapeutics at?

Drive Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 22, 2022.

MLA

"Drive Therapeutics — Funding & Investors." VCBacked, September 22, 2022, https://www.vcbacked.co/company/drive-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Drive Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/drive-therapeutics

Wikipedia (cite web)

{{cite web |title=Drive Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/drive-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 22, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.